Stock vs Stock Comparison

Becton, Dickinson and Company vs AbbVie Inc.

ABBV wins the Tale of the Tape 5–3.

BDX$145.61
ABBV$217.13

🏆 Tale of the Tape

35
BDXABBV
7.7%Profitability (Net Margin)6.9%
25.7xValuation (P/E)106.2x
4.2%Efficiency (ROIC)8.3%
7/9Health (Piotroski F)7/9
2.1Safety (Altman Z)2.0
8.2%Growth (Rev YoY)8.6%
-0.12Risk (Sharpe 1Y)0.61
1.18xBalance Sheet (D/E)-42.50x
3.67%FCF Yield4.23%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.308
252-Day Correlation
0.233
126-Day Correlation

Moderately correlated — some diversification benefit from holding both.

Fundamentals

MetricBDXABBV
Market Cap$40.5B$384.7B
P/E Ratio25.7x106.2x
Forward P/E11.0x13.4x
P/B1.68x-57.80x
Dividend Yield2.85%3.18%
Beta0.280.30

Quantitative Metrics

MetricBDXABBV
DCF Fair Value$330.12$126.26
DCF Upside+112.4%-38.9%
Piotroski F7/97/9
Altman Z2.102.01
Beneish M-2.63-2.87
FCF Yield3.67%4.23%
Net Debt/EBITDA3.4x3.0x
ROIC4.2%8.3%
WACC7.0%7.4%
ROIC – WACC-2.8pp0.8pp
Gross Margin45.4%70.2%
Net Margin7.7%6.9%
Rev Growth YoY8.2%8.6%
Sharpe (1Y)-0.120.61
Max Drawdown 3Y
FCF Payout Ratio45%65%

BDX Price

Loading chart...

ABBV Price

Loading chart...

ETF Exposure

BDX found in:

IHI4.64%
XHE1.53%
NOBL1.48%
SDY1.06%
XLV0.78%
VOE0.75%
VHT0.69%
VFVA0.55%
VO0.43%
VFMV0.39%
RSP0.20%
VIG0.19%
VYM0.18%
SCHV0.17%
VTV0.17%
DEM0.16%
IWD0.15%
SPYV0.14%
VONV0.13%
IVV0.10%
ESGV0.09%
SPLG0.09%
ITOT0.08%
SCHX0.08%
SCHB0.08%
VOO0.07%
SPY0.07%
SPTM0.06%
ACWI0.06%
VTI0.06%
VSS0.06%
VONE0.06%
URTH0.06%
VT0.04%
ONEO0.04%
QUS0.04%

ABBV found in:

XLV7.07%
IYH6.86%
VHT6.04%
HDV5.61%
SCHD3.53%
DGRO2.52%
DGRW1.99%
MGV1.85%
VIG1.68%
VYM1.56%
NOBL1.49%
VTV1.46%
SDY1.42%
IWF1.39%
SCHV1.38%
VONG1.21%
XBI1.09%
ESGV0.78%
SPYV0.71%
IVV0.69%
SPLG0.68%
SCHX0.66%
SCHB0.62%
ITOT0.61%
VOO0.60%
SPY0.59%
VONE0.57%
SPTM0.55%
VTI0.54%
SPYG0.50%
URTH0.48%
ACWI0.41%
VFVA0.41%
VT0.33%
QUS0.32%
VFMV0.25%
RSP0.19%
ONEO0.03%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

BDX vs ABBV: Head-to-Head Analysis

Becton, Dickinson and Company (BDX) and AbbVie Inc. (ABBV) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ABBV leads 5–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, BDX generates a return on invested capital (ROIC) of 4.2% compared to ABBV's 8.3%. This suggests ABBV is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between BDX and ABBV is 0.308, indicating moderate co-movement, with some diversification value from holding both in a portfolio context.

BDX appears in 36 ETFs tracked by SecuritiesDB, while ABBV appears in 38 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, BDX or ABBV?

Our quantitative analysis compares BDX and ABBV across nine fundamental dimensions. ABBV wins the Tale of the Tape 5–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are BDX and ABBV correlated?

The 252-day correlation between BDX and ABBV is 0.308. They show moderate correlation — partially diversifying.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.